Global Fluconazole Market 2023-2030

    In Stock

    Coming Soon




    An antifungal drug called fluconazole is used to treat a number of fungal infections, such as candidiasis, cryptococcal meningitis, and others. It functions by limiting the development of fungi’s cell walls and preventing their growth.


     There are three different forms of fluconazole: tablets, suspension, and injectable. It should be taken exactly as instructed, usually once day, and is typically recommended by a doctor.


    Depending on the exact ailment being treated as well as other variables including the patient’s age and general health, the dosage and length of treatment may change.


    Fluconazole can have adverse effects, however not everyone will experience them like they do with other medicines. Nausea, vomiting, diarrhea, headaches, and stomach pain are typical side effects.


    Although they are uncommon, more severe side effects such liver damage, severe allergic responses, and irregular heartbeat can occur.


    It’s crucial to call your doctor as soon as you notice any strange symptoms or side effects when taking fluconazole. They can give you advice on the best course of action and may need to change your prescription or dosage.




    infographic: Fluconazole Market, Fluconazole Market Size, Fluconazole Market Trends, Fluconazole Market Forecast, Fluconazole Market Risks, Fluconazole Market Report, Fluconazole Market Share


    Global Fluconazole market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.



    Brexafemme (ibrexafungerp), a novel treatment for vulvovaginal candidiasis, also referred to as vaginal yeast infection, was introduced by Scynexis.


    Brexafemme is prescribed for vulvovaginal candidiasis and costs significantly more than earlier azole medications like fluconazole.


    In a US research,  of women with recurrent vulvovaginal candidiasis who got oteseconazole eradicated their first yeast infection and saw no recurrences over the maintenance period, in contrast to  of women who received fluconazole and a placebo.


    Oteseconazole is an azole antifungal that is used to treat recurrent vulvovaginal candidiasis in postmenopausal or infertile women.


    The release of the Candida family of products, which includes a multiplex of Candida pathogens and reagents for fluconazole-resistant C. auris detection, was announced by ELITechGroup MDx LLC (EGMDx) Pathogens from the analyte-specific group C. neoformans, C. auris, A. fumigatus, and C.


    albicans are included in this novel line of real-time PCR products The COVID-19 pandemic, according to the Centers for Disease Control and Prevention, resulted in an overall increase in antifungal-resistant Candida and a considerable increase in infections of C. auris, which are both considered urgent and major public health problems.


    Diflucan (fluconazole), a brand-new antifungal medication, was introduced by Pfizer Products in Nigeria In comparative and non-comparative trials conducted in nations, including Nigeria, where the success rate was estimated to be  on average its clinical efficacy and safety have been established.



    • Pfizer Inc.
    • Teva Pharmaceuticals
    • Glenmark Pharmaceuticals
    • Cipla Limited
    • Dr. Reddy’s Laboratories
    • Sun Pharmaceutical Industries
    • Lupin Limited
    • Torrent Pharmaceuticals
    • Cadila Healthcare Limited
    • Aurobindo Pharma Limited



    1. How many Fluconazole are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global Fluconazole and key vendor selection criteria
    3. Where is the Fluconazole manufactured? What is the average margin per unit?
    4. Market share of Global Fluconazole market manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global Fluconazole in-house
    6. key predictions for next 5 years in Global Fluconazole market
    7. Average B-2-B Fluconazole market price in all segments
    8. Latest trends in Fluconazole market, by every market segment
    9. The market size (both volume and value) of the Fluconazole market in 2023-2030 and every year in between?
    10. Production breakup of Fluconazole market, by suppliers and their OEM relationship


    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2023-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2023-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2023-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2023-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop